Literature DB >> 10987272

Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

P C Chulada1, M B Thompson, J F Mahler, C M Doyle, B W Gaul, C Lee, H F Tiano, S G Morham, O Smithies, R Langenbach.   

Abstract

Two isoforms of cyclooxygenase (COX) are known, and to date most studies have implicated COX-2, rather than COX-1, as the isoform involved in colon carcinogenesis. In the present study, we show that homologous disruption of either Ptgs-1 or Ptgs-2 (genes coding for COX-1 or COX-2, respectively) reduced polyp formation in Min/+ mice by approximately 80%. Only COX-1 protein was immunohistochemically detected in normal intestinal tissue, whereas both COX-1 and variable levels of COX-2 protein were detected in polyps. Prostaglandin E2 was increased in polyps compared with normal tissue, and both COX-1 and COX-2 contributed to the PGE2 produced. The results indicate that COX-1, as well as COX-2, plays a key role in intestinal tumorigenesis and that COX-1 may also be a chemotherapeutic target for nonsteroidal anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987272

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  131 in total

Review 1.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 2.  Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

Authors:  C Patrono; P Patrignani; L A García Rodríguez
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  Why there are two cyclooxygenase isozymes.

Authors:  W L Smith; R Langenbach
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms.

Authors:  Daniel H Hwang; Victor Fung; Andrew J Dannenberg
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 5.  Regulated formation of eicosanoids.

Authors:  F A Fitzpatrick; R Soberman
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 6.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

Review 7.  Apoptosis and colorectal cancer.

Authors:  A J M Watson
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.

Authors:  Wei Li; Zhong-lei Ji; Guang-chao Zhuo; Ru-jun Xu; Jie Wang; Hong-ru Jiang
Journal:  Med Oncol       Date:  2009-02-24       Impact factor: 3.064

9.  Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.

Authors:  Mazin A Al-Salihi; Scott C Ulmer; Thao Doan; Cory D Nelson; Tracy Crotty; Stephen M Prescott; Diana M Stafforini; Matthew K Topham
Journal:  Cell Signal       Date:  2007-05-23       Impact factor: 4.315

10.  Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages.

Authors:  Xingmin Wang; Toby D Allen; Yonghong Yang; Danny R Moore; Mark M Huycke
Journal:  Cancer Prev Res (Phila)       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.